Literature DB >> 23224323

A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer.

Andrew Rundle1, Kathryn M Neckerman, Daniel Sheehan, Michelle Jankowski, Oleksandr N Kryvenko, Deliang Tang, Benjamin A Rybicki.   

Abstract

PURPOSE: Higher socioeconomic status (SES) men are at higher risk of prostate cancer (PCa) diagnosis, an association commonly interpreted as a function of higher rates of prostate screening among higher SES men. However, the extent to which screening explains this association has not been well quantified.
METHODS: Within a Detroit area cohort of 6,692 men followed up after a benign prostate procedure, a case-control study was conducted of 494 PCa cases and controls matched on age, race, duration of follow-up, and date of initial benign finding; 2000 Census data were used in a principal component analysis to derive a single factor, labeled the neighborhood SES index (NSESI), representing zip code-level SES.
RESULTS: Among cases, higher SES was associated with a younger age at initial biopsy: -1.48 years (95 % CI, -2.32, -0.64) per unit NSESI. After adjustment for confounders and duration of follow-up, higher SES was associated with more PSA tests and DRE during follow-up; 9 % (95 % CI, 2, 16) and 8 % (95 % CI, 1, 15) more respectively, per unit NSESI. Higher SES was associated with a higher risk of PCa diagnosis during follow-up, multivariable adjusted OR = 1.26 per unit increase in NSESI (95 % CI, 1.04, 1.49). Further adjustment for screening frequency somewhat reduced the association between SES and PCa risk (OR = 1.19 per unit NSESI, 95 % CI, 0.98, 1.44).
CONCLUSIONS: Differences in screening frequency only partially explained the association between higher zip code SES and PCa risk; other health care-related factors should also be considered as explanatory factors.

Entities:  

Mesh:

Year:  2012        PMID: 23224323      PMCID: PMC3557724          DOI: 10.1007/s10552-012-0108-6

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  39 in total

1.  Physician accessibility: an urban case study of pediatric providers.

Authors:  Mark F Guagliardo; Cynthia R Ronzio; Ivan Cheung; Elizabeth Chacko; Jill G Joseph
Journal:  Health Place       Date:  2004-09       Impact factor: 4.078

2.  A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma.

Authors:  Benjamin A Spencer; Susan H Babey; David A Etzioni; Ninez A Ponce; E Richard Brown; Hongjian Yu; Neetu Chawla; Mark S Litwin
Journal:  Cancer       Date:  2006-02-15       Impact factor: 6.860

3.  The social ecology of drug use: a factor analysis of an urban environment.

Authors:  D C Bell; J W Carlson; A J Richard
Journal:  Subst Use Misuse       Date:  1998-09       Impact factor: 2.164

4.  To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health.

Authors:  Alan E Hubbard; Jennifer Ahern; Nancy L Fleischer; Mark Van der Laan; Sheri A Lippman; Nicholas Jewell; Tim Bruckner; William A Satariano
Journal:  Epidemiology       Date:  2010-07       Impact factor: 4.822

5.  Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer.

Authors:  Oleksandr N Kryvenko; Michelle Jankowski; Dhananjay A Chitale; Deliang Tang; Andrew Rundle; Sheri Trudeau; Benjamin A Rybicki
Journal:  Mod Pathol       Date:  2012-03-30       Impact factor: 7.842

6.  Neighborhood socioeconomic status modifies the association between individual smoking status and PAH-DNA adduct levels in prostate tissue.

Authors:  Andrew Rundle; Catherine Richards; Christine Neslund-Dudas; Deliang Tang; Benjamin A Rybicki
Journal:  Environ Mol Mutagen       Date:  2012-03-29       Impact factor: 3.216

7.  Personal and neighborhood socioeconomic status and indices of neighborhood walk-ability predict body mass index in New York City.

Authors:  Andrew Rundle; Sam Field; Yoosun Park; Lance Freeman; Christopher C Weiss; Kathryn Neckerman
Journal:  Soc Sci Med       Date:  2008-10-25       Impact factor: 4.634

8.  Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups?

Authors:  Daixin Yin; Cyllene Morris; Mark Allen; Rosemary Cress; Janet Bates; Lihua Liu
Journal:  Cancer Causes Control       Date:  2010-06-22       Impact factor: 2.506

9.  The role of area-level influences on prostate cancer grade and stage at diagnosis.

Authors:  Ann C Klassen; Frank C Curriero; Jean Hee Hong; Chyvette Williams; Martin Kulldorff; Helen I Meissner; Anthony Alberg; Margaret Ensminger
Journal:  Prev Med       Date:  2004-09       Impact factor: 4.018

10.  Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures--the public health disparities geocoding project.

Authors:  Nancy Krieger; Jarvis T Chen; Pamela D Waterman; David H Rehkopf; S V Subramanian
Journal:  Am J Public Health       Date:  2003-10       Impact factor: 9.308

View more
  20 in total

1.  Incidence of second primary cancers in North Portugal-a population-based study.

Authors:  Luís Pacheco-Figueiredo; Luís Antunes; Maria José Bento; Nuno Lunet
Journal:  J Cancer Surviv       Date:  2015-07-10       Impact factor: 4.442

2.  Income and health-related quality of life among prostate cancer patients over a one-year period after radical prostatectomy: a linear mixed model analysis.

Authors:  Jens Klein; Daniel Lüdecke; Kerstin Hofreuter-Gätgens; Margit Fisch; Markus Graefen; Olaf von dem Knesebeck
Journal:  Qual Life Res       Date:  2017-04-25       Impact factor: 4.147

3.  Low-level arsenic exposure from drinking water is associated with prostate cancer in Iowa.

Authors:  Taehyun Roh; Charles F Lynch; Peter Weyer; Kai Wang; Kevin M Kelly; Gabriele Ludewig
Journal:  Environ Res       Date:  2017-09-18       Impact factor: 6.498

4.  Neighborhood walkability and body mass index in African American cancer survivors: The Detroit Research on Cancer Survivors study.

Authors:  Jamaica R M Robinson; Jennifer L Beebe-Dimmer; Ann G Schwartz; Julie J Ruterbusch; Tara E Baird; Stephanie S Pandolfi; Theresa A Hastert; James W Quinn; Andrew G Rundle
Journal:  Cancer       Date:  2021-08-18       Impact factor: 6.860

5.  [What do prostate cancer patients know about smoking? : Results of a bicentric questionnaire study (KRAUT study)].

Authors:  M May; C Gilfrich; P Spachmann; O Maurer; M K Dombrowski; H M Fritsche; M Wöhr; S Brookman-May; T Karl; M Schostak; M Burger; S Lebentrau
Journal:  Urologe A       Date:  2016-08       Impact factor: 0.639

Review 6.  A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies.

Authors:  Farhad Islami; Daniel M Moreira; Paolo Boffetta; Stephen J Freedland
Journal:  Eur Urol       Date:  2014-09-18       Impact factor: 20.096

7.  Impact of patient navigation in eliminating economic disparities in cancer care.

Authors:  Angie Mae Rodday; Susan K Parsons; Frederick Snyder; Melissa A Simon; Adana A M Llanos; Victoria Warren-Mears; Donald Dudley; Ji-Hyun Lee; Steven R Patierno; Talar W Markossian; Mechelle Sanders; Elizabeth M Whitley; Karen M Freund
Journal:  Cancer       Date:  2015-09-08       Impact factor: 6.860

8.  Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men.

Authors:  Daniella Klebaner; P Travis Courtney; Isla P Garraway; John Einck; Abhishek Kumar; Maria Elena Martinez; Rana McKay; James D Murphy; Humberto Parada; Ajay Sandhu; Tyler Stewart; Kosj Yamoah; Brent S Rose
Journal:  J Natl Cancer Inst       Date:  2021-10-01       Impact factor: 11.816

9.  Unemployment and prostate cancer mortality in the OECD, 1990-2009.

Authors:  Mahiben Maruthappu; Johnathan Watkins; Abigail Taylor; Callum Williams; Raghib Ali; Thomas Zeltner; Rifat Atun
Journal:  Ecancermedicalscience       Date:  2015-05-14

10.  Incidence and mortality trends of metastatic prostate cancer: Surveillance, Epidemiology, and End Results database analysis.

Authors:  Aaron C Zhang; Rehana Rasul; Anne Golden; Michael A Feuerstein
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.